Cannabinoid Receptors in Brain. Pharmacogenetics, Neuropharmacology, Neurotoxicology, and Potential Therapeutic Applications

International Review of Neurobiology

Volumn 88, Issue C, 2009, Pages 335-369

  Onaivi, Emmanuel S ^a  

^a WILLIAM PATERSON UNIVERSITY   (United States)

Author keywords

Cannabinoids; Endocannabinoids; Marijuana; Neurodegeneration; Neurogenesis; Neuroprotection; Neurotoxicity; Pharmacogenetics

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABIS; CAPSAICIN; DRONABINOL; LYSOPHOSPHATIDIC ACID RECEPTOR; NABILONE; RIMONABANT; VANILLOID RECEPTOR 1;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ATTENTION DEFICIT DISORDER; BEHAVIOR CHANGE; CANNABIS SMOKING; CHROMOSOME 1; CHROMOSOME 6; COCAINE DEPENDENCE; DEPRESSION; DRUG DEPENDENCE; EPILEPSY; GABAERGIC SYSTEM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOMICS; HUMAN; INTERVERTEBRAL DISK HERNIA; METABOLIC DISORDER; MULTIPLE SCLEROSIS; NAUSEA AND VOMITING; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NEUROPHARMACOLOGY; NEUROPROTECTION; NEUROTOXICOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; OBESITY; OSTEOPOROSIS; PAIN; PHARMACOGENETICS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SPASTICITY; SUICIDE; WASTING SYNDROME; WITHDRAWAL SYNDROME;

ANIMALS; BRAIN; CANNABINOIDS; HUMANS; RECEPTORS, CANNABINOID;

EID: 71749104726     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(09)88012-4     Document Type: Review

References (152)

1. Aberle J., Fedderwitz I., Klages N., George E., and Beil F.U. Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet. Horm. Metab. Res. 39 (2007) 395-397
2. Aberle J., Flitsch J., Beck N.A., Mann O., Busch P., Peitsmeier P., and Beil F.U. Genetic variation may influence obesity only under conditions of diet: Analysis of three candidate genes. Mol. Genet. Metab. 95 (2008) 188-191
3. Aceto M.D., Scates S.M., Lowe J.A., and Martin B.R. Dependence on delta 9-THC: Studies on precipitated and abrupt withdrawal. J. Pharmacol. Exp. Ther. 278 (1996) 1290-1295
4. Agrawal A., and Lynskey M.T. The genetic epidemiology of cannabis use, abuse and dependence. Addiction 101 (2006) 801-812
5. Agrawal A., and Lynskey M.T. Are there genetic influences on addiction: Evidence from family, adoption and twin studies?. Addiction 103 (2008) 1069-1081
6. Agrawal A., Morley K.I., Hansell N.K., Pergadia M.L., Montgomery G.W., Statham D.J., Todd R.D., Madden P.A., Heath A.C., Whitfield J., Martin N.G., Lynskey M.T., et al. Autosomal linkage analysis for cannabis use behaviors in Australian adults. Drug Alchol Depend. 98 (2008) 185-190
7. Agrawal A., Wetherill L., Dick D.M., Xuei X., Hinrichs A., Hesselbrock V., Kramer J., Nurnberger Jr. J.I., Schuckit M., Bierut L.J., Edenberg H.J., Foroud T., et al. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Am. J. Med. Genet. Part B 150 (2009) 736-740
8. Andersson H., D'Antona A.M., Kendall D.A., Von Heijne G., and Chin C.N. Membrane assembly of the cannabinoid receptor 1: Impact of a long N-terminal tail. Mol. Pharmacol. 64 (2003) 570-577
9. Ashton J.C., Friberg D., Darlington C.L., and Smith P.F. Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study. Neurosci. Lett. 396 (2005) 113-116
10. Ballon N., Leroy S., Roy C., Bourdel M.C., Charles-Nicolas A., Krebs M.O., and Poirier M.F. (AAT)n repeat in the cannabinoid receptor gene (CNR1): Association with cocaine addiction in an African-Caribbean population. Pharmacogenomics J. 6 (2006) 126-130
11. Barrero F.J., Ampuero I., Morales B., Vives F., De Dios Luna Del Castillo J., Hoenicka J., and García Yébenes J. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1). Pharmcogenomics J. 5 (2005) 135-141
12. Battista N., Pasquariello N., Di Tommaso M., and Maccarrone M. Interplay between endocannabinoids, steroids and cytokines in the control of human reproduction. J Neuroendocrinol. 20 (2008) 82-89
13. Beaulieu P. Toxic effects of cannabis and cannabinoids: Animal data. Pain Res. Manag. 10 (2005) 23A-26A
14. Beltramo M., Bernardini N., Bertorelli R., Campanella M., Nicolussi E., Fredduzzi S., and Reggiani A. CB2 receptor-mediated antihyperalgesia: Possible direct involvement of neural mechanisms. Eur. J. Neurosci. 23 (2006) 1530-1538
15. Benito C., Numez E., Tolon R.M., Carrier E.J., Rábano A., Hillard C.J., and Romero J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J. Neurosci. 23 (2003) 11136-11141
16. Benzinou M., Chevre J.C., Ward K.J., Lecoeur C., Dina C., Lobbens S., Durand E., Delplanque J., Horber F.F., Heude B., Balkau B., Borch-Johnsen K., et al. Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations. Hum. Mol. Genet. 17 (2008) 1916-1921
17. Bortolato M., Camolongo P., Mangieri R.A., Scattoni M.L., Frau R., Trezza V., La Rana G., Russo R., Calignano A., Gessa G.A., Cuomo V., Piomelli D., et al. Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31 (2006) 2652-2659
18. Brusco A., Tagliaferro P., Saez T., and Onaivi E.S. Ultrastructural localization of neuronal brain CB2 cannabinoid receptors. Ann. NY Acad. Sci. 1139 (2008) 450-457
19. Brusco A., Tagliaferro P., Saez T., and Onaivi E.S. Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse 62 (2008) 944-949
20. Bucholz K.K., Heath A.C., and Madden P.A. Transitions in drinking in adolescent female: Evidence from the Missouri adolescent female twin study. Alcohol Clin. Exp. Res. 24 (2000) 914-923
21. Buckland P.R. Genetic associations studies of alcoholism: Problems with the candidate gene approach. Alcohol Alcoholism 36 (2001) 99-102
22. Budney A.J. Are specific dependence criteria necessary for different substances: How can research on cannabis inform this issue?. Addiction 101 (2006) 125-133
23. Caenazzo L., Hoehe M.R., Hsieh W.-T., Berrettini W.H., Bonner T.I., and Gershon E.S. HindIII identifies a two allele DNA polymorphism of the human cannabinoid receptor gene (CNR). Nucleic Acids Res. 19 (1991) 4798
24. Cao Q., Martinez M., Zhang J., Sanders A.R., Badner J.A., Cravchik A., Markey C.J., Beshah E., Guroff J.J., Maxwell M.E., Kazuba D.M., Whiten R., et al. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics 43 (1997) 1-8
25. Chakrabarti A., Onaivi E.S., and Chaudhuri G. Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein. DNA Sequence 5 (1995) 385-388
26. Chakrabarti B., Kent L., Suckling J., Bullimore E., and Baron-Cohen S. Variations in the human cannabinoid receptor (CNR1) gene modulate striatal responses to happy faces. Eur. J. Neurosci. 23 (2006) 1944-1948
27. Chavarria-Siles I., Contrras-Rojas J., Hare E., Walss-Bass C., Quezada P., Dassori A., Contreras S., Medina R., Ramírez M., Salazar R., Raventos H., Escamilla M.A., et al. Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia. Am. J. Med. Genet. 147 (2008) 279-284
28. Chen X., Williamson V.S., An S.S., Hettema J.M., Aggen S.H., Neale M.C., and Kendler K.S. Cannabinoid receptor 1 gene association with nicotine dependence. Arch. Gen. Psychiatr. 65 (2008) 816-824
29. Cippitelli A., Bilbao A., Gorriti M.A., Navarro M., Massi M., Piomelli D., Ciccocioppo R., and de Fonseca R. The anandamide transport inhibitor AM404 reduces ethanol seld-adminiatration. Eur. J. Neurosci. 26 (2007) 476-486
30. Comings D.E. Genetic factors in drug abuse and dependence. NIDA Res. Monogr. 159 (1996) 16-48
31. Comings D.E., Muhleman D., Gade R., Johnson P., Verde R., Saucier G., and MacMurray J. Cannabinoid receptor gene (CNR1): Association with IV drug use. Mol. Psychiatr. 2 (1997) 161-168
32. Cook S.A., Lowe J.A., and Martin B.R. CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol. J. Pharmacol. Exp Ther. 285 (1998) 1150-1156
33. Cota D., Marsicano G., Lutz B., Vicennati V., Stalla G.K., Pasquali R., and Pagotto U. Endogenous cannabinoid system as a modulator of food intake. Int. J. Obes. 27 (2003) 289-301
34. Covault J., Gelernter J., and Kranzler H. Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence. Mol. Psychiatr. 6 (2001) 501-502
35. Crabbe J.C. Genetic contributions to addictions. Ann. Rev. Psychol. 53 (2002) 435-462
36. Dawson E. Identification of a polymorphic triplet marker for the brain cannabinoid receptor gene: Use in linkage and association studies of schizophrenia. Psychiatr. Genet. 5 (1991) S50
37. de Lago E., and Fernandez-Ruiz J. Cannabinoids and neuroprotection in motor-related disorders. CNS Neuro Disord. Drug Targets 6 (2007) 377-387
38. Dennedy M.C., Friel A.M., Houlihan D.D., Broderick V.M., Smith T., and Morrison J.J. Cannabinoids and human uterus during pregnancy. Am. J. Obstet. Gynecol. 190 (2004) 2-9
39. Domschke K., Dannlowski U., Ohrmann P., Lawford B., Bauer J., Kugel H., Heindel W., Young R., Morris P., Arolt V., Deckert J., Suslow T., et al. Cannabinoid receptor 1 (CNR1) gene: Impact on anti depressant treatment response and emotion processing in major depression. Eur. Neuropsychopharmacol. 18 (2008) 751-759
40. Ehlers C.L., Slutske W.S., Gilder D.A., and Lau P. Age of first marijuana use and the occurrence of marijuana use disorders in Southwest California Indians. Pharmacol. Biochem. Behav. 86 (2007) 290-296
41. Ehlers C.L., Slutske W.S., Lind P.A., and Wilhelmsen K.C. Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in South west California Indians. Twin Res. Hum. Genet. 10 (2007) 805-811
42. Gadzicki D., Muller-Vahl K., and Stuhrmann M. A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. Mol. Cell. Probes 13 (1999) 321-323
43. Gadzicki D., Müller-Vahl K.R., Heller D., Ossege S., Nöthen M.M., Hebebrand J., and Stuhrmann M. Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene. Am. J. Med. Genet. B Neuropsychiatr. Genet. 127 (2004) 97-103
44. Galve-Roperh I., Aguado T., Palazuelos J., and Guzman M. Mechanisms of control of neuron survival by the endocannabinoid system. Curr. Pharm. Des. 14 (2008) 2279-2288
45. Gazzero P., Caruso M.G., Notarnicola M., Misciagna G., Guerra V., Laezza C., and Bifulco M. Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population. Int. J. Obes. 31 (2007) 908-912
46. Gerard C.M., Mollereau C., Vassart G., and Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in the testis. Biochem. J. 279 (1991) 129-134
47. Gerhardt C.C., and van Heerikhuizen H. Functional characteristics of heterologously expressed 5-HT receptors. Eur. J. Pharmacol. 334 (1997) 1-23
48. Glaser S.T., Abumrad N.A., Fatade F., Kaczocha M., Studholme K.M., and Deutsch D.G. Evidence against the presence of an anandamide transporter. PNAS 100 (2003) 4269-4274
49. Glaser S.T., Kaczocha M., and Deutsch D.G. Anandamide transport: A critical review. Life Sci. 77 (2005) 1584-1604
50. Goncalves M.B., Suetterlin P., Yip P., Molina-Holgado F., Walker D.J., Oudin M.J., Zentar M.P., Pollard S., Yanez-Munoz R.J., Williams G., Walsh F.S., Pangalos M.N., et al. A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner. Mol. Cell. Neurosci. 38 (2008) 526-536
51. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., and Uhl G.R. Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain. Brain Res. 1071 (2006) 10-23
52. Gonsiorek W., Lunn C., Fan X., Narula S., Lundell D., and Hipkin R.W. Endocannabinoid 2-Arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: Antagonism by anandamide. Mol Pharmacol. 57 (2000) 1045-1050
53. Grotenhermen F. Pharmacology of cannabinoids. Neuroendocrinol. Lett. 25 (2004) 14-23
54. Gurwitz D., and Kloog Y. Do endogenous cannabinoids contribute to HIV-mediated immune failure?. Mol. Med. Today 4 (1998) 196-200
55. Haile C.N., Kosten T.A., and Kosten T.R. Pharmagenetic treatments for drug addiction: Alcohol and opiates. Am. J. Drug Alcohol Abuse 34 (2008) 355-381
56. Hamdani N., Tabeze J.-P., Ramoz N., Ades J., Hamon M., Sarfati Y., Boni C., and Gorwood P. The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia. Eur. Neuropsychopharmacol. 18 (2008) 34-40
57. Haughey H.M., Marshall E., Schacht J.P., Louis A., and Hutchison K.E. Marijuana withdrawal and craving: Influence of the cannabinoid 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction 103 (2008) 1678-1686
58. Heller D., Schneider U., Seifert J., Cimander K.F., and Stuhrmann M. The cannabinoid receptor gene (CNR1 is not affected in German i.v. drug users. Addict. Biol. 6 (2001) 183-187
59. 2+ signaling and NFAT activation. FASEB J. 23 (2008) 183-193
60. Herman A.I., Kranzler H.R., Cubells J.F., Gelernter J., and Covault J. Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance abuse. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B (2006) 499-503
61. Hermann A., Kaczocha M., and Deutsch D.G. 2-Arachidonylglycerol (2-AG) membrane transport: History and outlook. AAPS J. 8 (2006) E409-E412
62. Hillard C.J., Harris R.A., and Bloom A.S. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: Fluorescence studies. J. Pharmacol. Exp. Ther. 232 (1985) 579-588
63. Hoehe M.R., Caenazzo L., Martinez M.M., Hsieh W.T., Modi W.S., Gershon E.S., and Bonner T.I. Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15. New Biologist 3 (1991) 880-885
64. Hoenicka J., Ponce G., Jimenez-Arriero M.A., Ampuero I., Rodríguez-Jiménez R., Rubio G., Aragüés M., Ramos J.A., and Palomo T. Association in alcoholic patients between psychopathic traits and the additive effect of allelic forms of CNR1 and FAAH endocannabinoid genes, and the 3′ region of the DRD2 gene. Neurotox Res. 11 (2007) 51-60
65. Hopfer C.J., Stallings M.C., Hewith J.K., and Crowley T.J. Family transmission of marijuana use, abuse, and dependence. J. Am. Acad. Child Adolesc. Psychiatr. 42 (2003) 834-841
66. Hopfer C.J., Young S.E., Purcell S., Crowley T.J., Stallings M.C., Corley R.P., Rhee S.H., Smolen A., Krauter K., Hewitt J.K., and Ehringer M.A. Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141 (2006) 895-901
67. Hopfer C.J., Lessem J.M., Hartman C.A., Stallings M.C., Cherny S.S., Corley R.P., Hewitt J.K., Krauter K.S., Mikulich-Gilbertson S.K., Rhee S.H., Smolen A., Young S.E., et al. A genome-wide scan influencing adolescent cannabis dependence symptoms: Evidence for linkage on chromosomes 3 and 9. Drug Alchol Depend. 89 (2007) 34-41
68. Hungund B.L., Vinod K.Y., Kassir S.A., Basavarajappa B.S., Yalamanchili R., Cooper T.B., Mann J.J., and Arango V. Upregulation of CB1 receptors and agonist-stimulated [35]GTPgammaS binding in the prefrontal cortex of depressed suicide victims. Mol. Psychiatr. 9 (2004) 184-190
69. Hutchison K.E., Haughley H., Niculescu M., Schacht J., Kaiser A., Stitzel J., Horton W.J., and Filbey F. The incentive salience of alcohol: Translating the effects of genetic variant in CNR1. Arch. Gen. Psychiatr. 65 (2008) 841-850
70. Ishiguro H., Iwasaki S., Teasenfitz L., Higuchi S., Horiuchi Y., Saito T., Arinami T., and Onaivi E.S. Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans. Pharmacogenomics J. 7 (2007) 380-385
71. Iversen L.L. The Science of Marijuana (2000), Oxford University Press, Inc., New York
72. Jaeger J.P., Mattevi V.S., Callegri-Jacques S.M., and Hutz M.H. Cannabinoid type-1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population. Dis. Markers 25 (2008) 67-74
73. Jesudason D., and Wittert G. Endocannabinoid system in food intake and metabolic regulation. Curr. Opin. Lipidol. 19 (2008) 344-348
74. Jhaveri M.D., Elmes S.J., Richardson D., Barrett D.A., Kendall D.A., Mason R., and Chapman V. Evidence for a novel functional role of cannabinoid CB(2) receptors in the thalamus of neuropathic rats. Eur. J. Neurosci. 27 (2008) 1722-1730
75. Johnson J.P., Muhleman D., MacMurray J., Gade R., Verde R., Ask M., Kelley J., and Comings D.E. Association between the cannabinoid receptor gene (CNR1) and the P300 event-related potential. Mol. Psychiatr. 2 (1997) 169-171
76. Karsak M., Cohen-Solal M., Freudenberg J., Ostertag A., Morieux C., Kornak U., Essig J., Erxlebe E., Bab I., Kubisch C., de Vernejoul M.C., and Zimmer A. Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum. Mol. Genet. 14 (2005) 3389-3396
77. Karsak M., Gaffal E., Date R., Wang-Eckhardt L., Rehnelt J., Petrosino S., Starowicz K., Steuder R., Schlicker E., Cravatt B., Mechoulam R., and Buettner R. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316 (2007) 1494-1497
78. Kathmann M., Haug K., Heils A., Nothen M.M., and Schlicker E. Exchange of three amino acids in the cannabinoid CB1 receptor (CNR1) of an epilepsy patient. Symposium on the Cannabinoids, Burlington, Vermont, ICRS Abst (2000) 18
79. Kwon J.M., and Goate A.M. The candidate gene approach. Alcohol Res. Health 24 (2000) 164-168
80. Lauckner J.E., Jensen J.B., Chen H.-Y., Lu H.C., Hille B., and Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. PNAS 105 (2008) 2699-2704
81. Leroy S., Griffon N., Bourdel M.C., Olié J.P., Poirier M.F., and Krebs M.O. Schizophrenia and the cannabinoid receptor type 1 (CB1): Association study using a single-base polymorphism in coding exon 1. Am. J. Med. Genet. 105 (2001) 749-752
82. Li J.-H., and Lin L.-F. Genetic toxicology of abused drugs: A brief review. Mutagenesis. 13 (1998) 557-565
83. Li T., Liu X., Zhu Z.H., Zhao J., Hu X., Ball D.M., Sham P.C., and Collier D.A. No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population. Mol. Psychiatr. 5 (2000) 128-130
84. Lovinger D.M. Presynaptic modulation by endocannabinoids. Handb. Exp. Pharmacol. 184 (2008) 435-477
85. Lu A.T., Ogdie M.N., Järvelin M.R., Moilanen I.K., Loo S.K., McCracken J.T., McGough J.J., Yang M.H., Peltonen L., Nelson S.F., Cantor R.M., Smalley S.L., et al. Association of the cannabinoid receptor gene (CNR1) with ADHD and post-traumatic stress disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147 (2008) 1488-1489
86. Makriyannis A., Banijamali A., Jarrell H.C., and Yang D.P. The orientation of (-)-delta-9-tetrahydrocannabinol in DPPC bilayers as determined by solid state 2H-NMR. Biochim. Biophys. Acta. 986 (1989) 141-145
87. Martinez M., Goldin L.R., Cao Q., Zhang J., Sanders A.R., Nancarrow D.J., Taylor J.M., Levinson D.F., Kirby A., Crowe R.R., Andreasen N.C., Black D.W., et al. Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q. Am. J. Med. Genet. 88 (1999) 337-343
88. Martinez-Gras I., Hoenicka J., Ponce G., Rodríguez-Jiménez R., Jiménez-Arrierom M.A., Pérez-Hernandez E., Ampuero I., Ramos-Atance J.A., Palomo T., and Rubio G. (AAT)n repeat in the cannabinoid receptor gene, CNR1: Association with schizophrenia in a Spanish population. Eur. Arch. Psychiatr. Clin. Neurosci. 256 (2006) 437-441
89. Mato S., Olmo E.D., and Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Euro. J. Neurosci. 17 (2003) 1747-1754
90. Matsuda L.A. Molecular aspects of cannabinoid receptors. Crit. Rev. Neurobiol. 11 (1997) 143-166
91. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., and Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346 (1990) 561-564
92. Matyas F., Yanovsky Y., Mackie K., Kelsch W., Misgeld U., and Freund T.F. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience 137 (2006) 337-361
93. Mechoulam R., and Shohami E. Endocannabinoids and traumatic brain injury. Mol. Neurobiol. 36 (2007) 68-74
94. Muller T.D., Reichwald K., Wermter A.-K., Brönner G., Nguyen T.T., Friedel S., Koberwitz K., Engeli S., Lichtner P., Meitinger T., Schäfer H., and Hebebrand J. No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1 in obesity in German children and adolescents. Mol. Genet. Metabol. 90 (2007) 429-434
95. Muller T.D., Reichwald K., Bronner G., Kirschner J., Nguyen T.T., Scherag A., Herzog W., Herpertz-Dahlmann B., Lichtner P., Meitinger T., Platzer M., and Schafer H. Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa. Child Adolesc Psychiatr. Health. 2 (2008) 33-40
96. Munro S., Thomas K.L., and Abu-Shaar M. Molecular characterization of a peripheral cannabinoid receptor. Nature 365 (1993) 61-65
97. Murphy W.J., Elzirik E., Johnson W.E., Zhang Y.P., Ryder O.A., and O'Brien S.J. Molecular phylogenetics and origins of placental mammals. Nature 409 (2001) 614-618
98. Nordstrom R., and Andersson H. Amino-terminal processing of the human cannabinoid receptor 1. J. Receptor Signal Transduction 26 (2006) 259-267
99. Norrod A.G., and Puffenbarger R.B. Genetic polymorphisms of the endocannabinoid system. Chem. Biodivers. 4 (2007) 1926-1932
100. Nunez E., Benito C., Pazos M.R., Barbachano A., Fajardo O., González S., Tolón R.M., and Romero J. Cannabinoid CB2 receptors are expressed by perivascular microglia cells in the human brain: An immunohistochemical study. Synapse 53 (2004) 208-213
101. Oka S., Nakajima K., Yamashita A., Kishimoto S., and Sugiura T. Identification of GPR55 as a lysophosphatidyinositol receptor. Biochem. Biophys. Res. Com. 362 (2007) 928-934
102. Oka S., Toshida T., Maruyama K., Nakajima K., Yamashita A., and Sugiura T. 2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55. J. Biochem. 145 (2008) 13-20
103. Okamoto Y., Morishita J., Tsuboi K., Tonai T., and Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279 (2004) 5298-5305
104. Oliva J.M., Ortiz S., Palomo T., and Manzanares J. Behavioral and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice. J. Neurochem. 85 (2003) 94-104
105. Onaivi E.S. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 54 (2006) 231-246
106. Onaivi E.S. An endocannabinoid hypothesis of drug reward and drug addiction. Ann. NY Acad. Sci. 1139 (2008) 412-421
107. Onaivi E.S., Chakrabarti A., and Chaudhuri G. Cannabinoid receptor genes. Prog. Neurobiol. 48 (1996) 275-305
108. Onaivi E.S., Chaudhuri G., Abaci A.S., Parker M., Manier D.H., Martin P.R., and Hubbard J.R. Expression of cannabinoid receptors and their gene transcripts in human blood cells. Prog. Neuropsychopharmacol. Biol. Psychiatr. 23 (1999) 1063-1077
109. Onaivi E.S., Ishiguro H., Lin Z., Akinshola B.E., Zhang P.-W., and Uhl G.R. Cannabinoid receptor genetics and behavior. In: Onaivi E.S. (Ed). Biology of Marijuana: From Gene to behavior (2002), CRC Press, Taylor and Francis Group, Boca Raton 1-44
110. Onaivi E.S., Leonard C.M., Ishiguro H., Zhang P.W., Lin Z., Akinshola B.E., and Uhl G.R. Endocannabinoids and cannabinoid receptor genetics. Prog. Neurobiol. 66 (2002) 307-344
111. Onaivi E.S., Ishiguro H., Gong J.P., Patel S., Perchuk A., Meozzi P.A., Myers L., Mora Z., Tagliaferro P., Gardner E., Brusco A., Akinshola B.E., et al. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann. NY Acad. Sci. 1074 (2006) 514-536
112. Onaivi E.S., Ishiguro H., Zhang P.-W., Lin Z., Akinshola B.E., Leonard C.M., Chirwa S.S., Gong J.-P., and Uhl G.R. Endocannabinoid receptor genetics and marijuana use. In: Onaivi E.S., Sugiura T., and DiMarzo V. (Eds). Endocannabinoids: The Brain and Body's Marijuana and Beyond (2006), CRC Press, Taylor and Francis Group, Boca Raton 57-118
113. Onaivi E.S., Ishiguro H., Gong J.P., Patel S., Meozzi P.A., Myers L., Perchuk A., Mora Z., Tagliaferro P.A., Gardner E., Brusco A., Akinshola B.E., et al. Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: From mice to human subjects. PLoS ONE 3 (2008) e1640
114. Onaivi E.S., Ishiguro H., Gong J.P., Patel S., Meozzi P.A., Myers L., Perchuk A., Mora Z., Tagliaferro P.A., Gardner E., Brusco A., Akinshola B.E., et al. Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Ann. NY Acad. Sci. 1139 (2008) 434-449
115. Palomo T., Kostrzewa R.M., Beninger R.J., and Archer T. Genetic variation and spared biological susceptibility underlying comorbidity in neuropsychiatry. Neurotox. Res. 12 (2007) 29-42
116. Park B., Gibbons H.M., Mitchell M.D., and Glass M. Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta 24 (2003) 990-995
117. Pazos M.R., Nunez E., Benito C., Tolón R.M., and Romero J. Role of the endocannabinoid system in Alzheimers's disease: New perspectives. Life Sci. 75 (2004) 1907-1915
118. Peeters A., Beckers S., Mertens I., Van Hul W., and Van Gaal L. The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men. Endocrine 31 (2007) 138-141
119. Petitet F., Donlan M., and Michel A. GPR55 as a new cannabinoid recptor: Still a long way to prove it. Chem. Biol. Drug Des. 67 (2006) 252-253
120. Ponce G., Hoenicka J., Rubio G., Ampuero I., Jiménez-Arriero M.A., Rodríguez-Jiménez R., Palomo T., and Ramos J.A. Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients. Mol. Psychiatr. 8 (2003) 466-467
121. Preuss U.W., Koller G., Zill P., Bondy B., and Soyka M. Alcoholism related phenotypes and genetic variants of the CB1 receptor. Eur. Arch. Psychiatr. Clin. Neurosci. 253 (2003) 275-280
122. Reinhard W., Stark K., Neureuther K., Sedlacek K., Fischer M., Baessler A., Weber S., Kaess B., Wiedmann S., Erdmann J., Lieb W., Jeron A., et al. Common polymorphisms in the cannabinoid CB2 gene (CNR2) are not associated with myocardial infarction and cardiovascular risk factors. Int. J. Mol. Med. 22 (2008) 165-174
123. Rinaldi-Carmona M., Calandra B., Shire D., Bouaboula M., Oustric D., Barth F., Casellas P., Ferrara P., and Le Fur G. Characterization of two cloned CB1 cannabinoid receptor isoforms. J. Pharmacol. Exp. Ther. 278 (1996) 871-878
124. Russo P., Strazzullo P., Cappuccio F.P., Tregouet D.A., Lauria F., Loguercio M., Barba G., Versiero M., and Siani A. Genetic variations at the endocannabinoid type 1 receptor gene (CNR1) are associated with obesity phenotype in men. J. Clin. Endocrinol. Metabol. 92 (2007) 2382-2386
125. Salamone J.D., Correa M., Mingote S.M., and Weber S.M. Beyond the reward hypothesis: Alternative functions of nucleus accumbens dopamine. Curr. Opin. Pharmacol. 5 (2005) 34-41
126. Samson M.-T., Small-Howard A., Shimoda L.M., Koblan-Huberson M., Stokes A.J., and Turner H. Differential roles of CB1 and CB2 cannabinoid receptors in Mast cells. J. Immunol. 170 (2003) 4953-4962
127. Schatz A.R., Lee M., Condie R.B., Pulaski J.T., and Kaminski N.E. Cannabinoid receptors CB1 and CB2: A characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol. 142 (1997) 278-287
128. Schmidt L.G., Samochowiec J., Finckh U., Fiszer-Piosik E., Horodnicki J., Wendel B., Rommelspacher H., and Hoehe M.R. Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe dependence. Drug Alcohol Depend. 65 (2002) 221-224
129. Serra G., and Fratta W. A possible role for the endocannabinoid system in the neurobiology of depression. Clin. Practice Epidemiol. Mental Health 3.25 (2007) 1-11
130. Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., Le Fur G., Caput D., and Ferrara P. An amino terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270 (1995) 3726-3731
131. Siegfried Z., Kanyas K., Latzer Y., Karni O., Bloch M., Lerer B., and Berry E.M. Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: Differences between restricting and binging/purging subtypes. Am. J. Med. Genet. B Neuropsychiatr. Genet. 125 (2004) 126-130
132. Sipe J.C., Arbour N., Gerber A., and Beutler E. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: Possible risk for autoimmune disorders. J. Leukoc. Biol. 78 (2005) 231-238
133. Smith N.T. A review of the published literature into cannabis withdrawal symptoms in human users. Addiction 97 (2002) 621-632
134. Spanagel R., and Weiss F. The dopamine hypothesis of reward: Past and current status. Trend. Neurosci. 22 (1999) 521-527
135. Stubbs L., Chittenden L., Chakrabarti A., and Onaivi E.S. The mouse cannabinoid receptor gene is located in proximal chromosome 4. Mammal. Genome. 7 (1996) 165-166
136. Sugiura T., Kodaka T., Nakane S., Miyashita T., Kondo S., Suhara Y., Takayama H., Waku K., Seki C., Baba N., and Ishima Y. Evidence that cannabinoid CB1 receptor is a 2-arachidonyl glycerol receptor. J. Biol. Chem. 274 (1999) 2794-2801
137. Sugiura T., Kishimoto S., Oka S., and Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonyl glycerol, an endogenous cannabinoid receptor ligand. Prog. Lip. Res. 45 (2006) 405-446
138. Tsai S.J., Wang Y.C., and Hong C.J. Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia. Psychiatr. Genet. 10 (2000) 149-151
139. Tsai S.J., Wang Y.C., and Hong C.J. Association study between cannabinoid receptor gene (CNR1) and pathogenesis and psychotic symptoms of mood disorders. Am. J. Med. Genet. 105 (2001) 219-221
140. Tyndale R.F. Genetics of alcohol and tobacco use in humans. Ann. Med. 35 (2003) 94-121
141. Ujike H., Takaki M., Nakata K., Tanaka Y., Takeda T., Kodama M., Fujiwara Y., Sakai A., and Kuroda S. CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia. Mol. Psychiatr. 7 (2002) 515-518
142. Van Der Stelt V., and Di Marzo. Cannabinoid receptors and their role in neuroprotection. Neuromolecular Med. 7 (2005) 37-50
143. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., Marnett L.J., Di Marzo V., et al. Identification and functional characterization of brain stem cannabinoid CB2 receptors. Science 27 (2005) 539-545
144. Vasquez C., and Lewis D.L. The CB1 cannabinoid receptor can sequester G-proteins, making them unavailable to couple to other receptors. J. Neurosci. 19 (1999) 9271-9280
145. Walter L., and Stella N. Cannabinoids and neuroinflammation. Br. J. Pharmacol. 141 (2004) 775-785
146. Wan M., Cravatt B.F., Ring H.Z., Zhang X., and Francke U. Conserved chromosomal location and genomic structure of human and mouse fatty-acid amide hydrolase genes and evaluation of clasper as a candidate neurological mutation. Genomics 54 (1998) 408-414
147. Wang X., Dow-Edwards D., Keller E., and Hurd Y.L. Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain. Neurosci 118 (2003) 681-694
148. Woolmore J.A., Stone M.J., Holley S., Jenkinson P., Ike A., Jones P., Fryer A., Strange R., Stephens R., Langdon D., and Hawkins C. Polymorphism of the cannabinoid 1 recpetor gene and cognitive impairment in multiple sclerosis. Mult. Scler. 14 (2008) 177-182
149. Yamada Y., Ando F., and Shimkata H. Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men. Int. J. Mol. Med. 19 (2007) 791-801
150. Young S.E., Rhee S.H., Stallings M.C., Corley R.P., and Hewitt J.K. Genetic and environmental vulnerabilities underlying adolescent substance use and problem use: General or specific?. Behavior. Genet. 36 (2006) 603-615
151. Zhang P.W., Ishiguro H., Ohtsuki T., Hess J., Carillo F., Walther D., Onaivi E.S., Arinami T., and Uhl G.R. Human cannabinoid receptor 1:5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol. Psychiatr. 9 (2004) 916-931
152. Zuo L., Kranzler H.R., Luo Z., Covault J., and Gelernter J. CNR1 variation modulates risk for drug and alcohol dependence. Biol. Psychiatr. 62 (2007) 616-626